REGULUS THERAPEUTICS INC's ticker is RGLSXXXX and the CUSIP is 75915K101. A total of 70 filers reported holding REGULUS THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is 3.91 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $58,000 | +70.6% | 292,638 | +796.8% | 0.00% | – |
| Q4 2017 | $34,000 | -46.0% | 32,631 | -48.6% | 0.00% | – |
| Q2 2017 | $63,000 | -24.1% | 63,452 | +25.1% | 0.00% | – |
| Q1 2017 | $83,000 | -52.6% | 50,708 | -34.8% | 0.00% | – |
| Q4 2016 | $175,000 | +113.4% | 77,768 | +211.5% | 0.00% | – |
| Q3 2016 | $82,000 | -90.7% | 24,967 | -91.8% | 0.00% | – |
| Q2 2016 | $882,000 | -15.3% | 305,018 | +103.2% | 0.00% | – |
| Q1 2016 | $1,041,000 | -14.7% | 150,097 | +7.3% | 0.00% | – |
| Q4 2015 | $1,220,000 | -74.5% | 139,878 | -80.9% | 0.00% | -100.0% |
| Q3 2015 | $4,777,000 | +58.7% | 730,531 | +166.1% | 0.00% | +100.0% |
| Q2 2015 | $3,010,000 | -41.5% | 274,570 | -9.6% | 0.00% | -50.0% |
| Q1 2015 | $5,144,000 | +24.2% | 303,613 | +17.5% | 0.00% | +100.0% |
| Q4 2014 | $4,143,000 | – | 258,335 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 4,039,823 | $26,420,000 | 3.79% |
| Foresite Capital Management II, LLC | 1,750,269 | $11,447,000 | 3.48% |
| ARGONAUT CAPITAL MANAGEMENT CORP | 75,000 | $491,000 | 1.65% |
| Abingworth LLP | 327,350 | $2,138,000 | 1.25% |
| Trellus Management Company, LLC | 100,000 | $654,000 | 0.96% |
| Cormorant Asset Management, LP | 896,522 | $5,863,000 | 0.94% |
| DAFNA Capital Management LLC | 90,000 | $589,000 | 0.58% |
| ORACLE INVESTMENT MANAGEMENT INC | 749,064 | $4,898,000 | 0.50% |
| Foresite Capital Management II, LLC | 250,000 | $1,635,000 | 0.50% |
| Foresite Capital Management II, LLC | 250,000 | $1,635,000 | 0.50% |